South Africa Drug Device Combination Products Market Size & Outlook

The drug device combination products market in South Africa is expected to reach a projected revenue of US$ 1,620.5 million by 2030. A compound annual growth rate of 7.5% is expected of South Africa drug device combination products market from 2024 to 2030.
Revenue, 2023 (US$M)
$977.1
Forecast, 2030 (US$M)
$1,620.5
CAGR, 2024 - 2030
7.5%
Report Coverage
South Africa

South Africa drug device combination products market, 2018-2030 (US$M)

South
Unlock Premium

Related Markets

South Africa drug device combination products market highlights

  • The South Africa drug device combination products market generated a revenue of USD 977.1 million in 2023 and is expected to reach USD 1,620.5 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
  • In terms of segment, transdermal patches was the largest revenue generating product in 2023.
  • Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.


Drug device combination products market data book summary

Market revenue in 2023USD 977.1 million
Market revenue in 2030USD 1,620.5 million
Growth rate7.5% (CAGR from 2023 to 2030)
Largest segmentTransdermal patches
Fastest growing segmentDrug Eluting Stents
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhotodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters
Key market players worldwideAbbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.7% of the global drug device combination products market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa drug device combination products market is projected to lead the regional market in terms of revenue in 2030.
  • Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 543.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Device Combination Products Market Scope

Drug device combination products market segmentation & scope
Photodynamic Therapy Devices
Transdermal Patches
Wound Care Products
Others
Volumetric
Disposables
Syringes
Ambulatory
Implantable
Insulin
Bone Graft Implants
Antibiotic Bone Cement
Coronary Stents
Peripheral Vascular Stents
Dry Powder
Nebulizers
Metered Dose
Urological
Cardiovascular
Others

Drug Device Combination Products Market Companies

Name Profile # Employees HQ Website

South Africa drug device combination products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.


Transdermal patches was the largest segment with a revenue share of 23.08% in 2023. Horizon Databook has segmented the South Africa drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.


Factors such as rising healthcare spending, growing prevalence of cancer, and increasing number of minimally invasive surgeries are expected to drive market growth in South Africa during the forecast period. Furthermore, the government in the country has been adopting measures to improve the state of healthcare facilities.

The government allocates 11% of the resources to the healthcare sector from the total government expenditure. There are more than 200 private hospitals and over 400 public hospitals in the country. About 40% of the total healthcare expenditure is carried out by the government. Due to this, the private sector is under pressure to provide appropriate services to most citizens.

This is expected to drive the market in the near future. The rising prevalence of chronic diseases like cancer & diabetes in the country may offer lucrative opportunities for the market. For instance, according to the International Diabetes Federation, diabetes prevalence reached 11.3% and accounted for 96,000 deaths in South Africa in 2021.

Reasons to subscribe to South Africa drug device combination products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Africa drug device combination products market databook

  • Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into South Africa drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Africa drug device combination products market size, by product, 2018-2030 (US$M)

South Africa Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)

South Africa drug device combination products market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more